Results 61 to 70 of about 16,326 (177)

Intramuscular pathways of maladaptation in overtraining syndrome

The Journal of Physiology, EarlyView.
Abstract figure legend The transition from adaptive overreaching to maladaptive overtraining and mechanisms through which excessive training load can lead to performance decline. Four interconnected pathophysiological domains are highlighted: neural fatigue, involving both central and peripheral components such as altered sensory feedback and reflex ...
Emily Shorter, Oscar Horwath, Sabrina Tzivia Barsky, Ferdinand von Walden, Johanna T. Lanner   +4 more
wiley   +1 more source

Polymyositis - An overdiagnosed entity

, 2003
Background: According to widely used criteria (Bohan and Peter criteria, 1975), dermatomyositis (DM) is differentiated from polymyositis (PM) only by skin changes. More recent criteria also include histopathologic characteristics enabling the distinction
van Venrooij, WJ, Wokke, JHJ, Hoogendijk, JE, Burger, H; id_orcid, Dinant, HJ, de Visser, M, van der Meulen, MFG, Bronner, IM, Linssen, WHJP, Voskuyl, AE   +9 more
core   +2 more sources

An electrophysiological investigation of skeletal muscles in polymyositis Investigação eletrofisiológica de músculos esqueléticos na polimíosite

Arquivos de Neuro-Psiquiatria, 1976
An electrophysiological study has been made of the extensor digitorum brevis, thenar and hypothenar muscles in 25 patients with chronic and acute polymyositis.
R. E. P. Sica, Olga P. Sanz, Nidia Aguilera, A. Colombi   +3 more
doaj  

Polymyositis and dermatomyositis – challenges in diagnosis and management

Journal of Translational Autoimmunity, 2019
Polymyositis (PM) and dermatomyositis (DM) are different disease subtypes of idiopathic inflammatory myopathies (IIMs). The main clinical features of PM and DM include progressive symmetric, predominantly proximal muscle weakness.
Shu-Han Yang, Christopher Chang, Zhe-Xiong Lian   +2 more
doaj   +1 more source

Haemostatic changes and bleeding with anti‐IL‐6 directed therapy in autoimmune diseases

British Journal of Pharmacology, Volume 183, Issue 15, Page 4111-4125, August 2026.
Abstract Anti‐IL‐6 directed therapy, especially tocilizumab (TCZ), is widely used for the treatment of autoimmune diseases such as rheumatoid arthritis, giant cell arteritis and systemic juvenile idiopathic arthritis. Next to being a master regulator of inflammation, IL‐6 also is an important regulator of haemostasis. Although generally well tolerated,
Charlotte D. C. C. van der Heijden, Loes C. Oskam, Lenny van Bon, Chantal P. Rovers   +3 more
wiley   +1 more source

International Myositis Assessment and Clinical Studies Guidelines for Risk‐Based Cancer Screening: An External Validation in Patients With Dermatomyositis Seen at a Metropolitan Academic Center

ACR Open Rheumatology, Volume 8, Issue 7, July 2026.
Objective Dermatomyositis (DM) is an idiopathic inflammatory myopathy (IIM) characterized by muscle weakness, skin findings, and increased malignancy risk. Cancer risk is greatest in the three years before or after DM onset, termed paraneoplastic DM.
Isabel Silva, Jasper Dayanan, Alexandra Nigro, Capriana Jiang, Ma Georgina Erfe, Trixie Rivera, Saakshi Khattri   +6 more
wiley   +1 more source

Polymyositis and dermatomyositis

, 1988
Polymyositis and Dermatomyositis provides extensive information regarding Polymyositis and Dermatomyositis (PM/DM), which is described as a heterogeneous disease complex.
Dalakas, Marinos C.
core  

Biomaterial design strategies for enhancing mitochondrial transplantation therapy

BMEMat, Volume 4, Issue 2, June 2026.
Biomaterials to facilitate mitochondrial transplantation therapy: biomaterials as barriers to protect mitochondria from pathophysiological microenvironments, like osmotic stress caused by the excessive concentration of calcium ion, reactive oxygen species, and advanced glycation end products; biomaterials integrating with biochemical cues to improve ...
Shaoyang Kang, Yushan Zhang, Hang Li, Sirui Peng, Donghao Lyu, Chunxiao Zhou, Sheng Ding, Zujian Feng, Pingsheng Huang, Chuangnian Zhang, Hongjun Wang, Deling Kong, Weiwei Wang   +12 more
wiley   +1 more source

A polymyositis és a dermatomyositis legújabb gyógyszeres terápiája

, 2013
A polymyositis és a dermatomyositis legújabb gyógyszeres terápiájának bemutatása, hangsúlyozva a szövődményes esetek, illetve a napjainkban egyre gyakrabban előforduló refrakter esetek kezelését.SZGáltalános orvostudományinappalimagyaregységes ...
Izsák, Erika
core  

A case of juvenile polymyositis post viral hepatitis A

, 2017
Polymyositis is rare as a stand-alone entity and is often misdiagnosed; most patients whose condition has been diagnosed as polymyositis have inclusion-body myositis, necrotizing autoimmune myositis, or inflammatory dystrophy.
N. K. Thulaseedharan, Hanock Unni Samuel, N. V. Jayachandran   +2 more
core   +1 more source